“Cemiplimab Improves Health-Related Quality of Life (HRQoL) and Reduces Pain in Patients With Advanced Cutaneous Squamous Cell Carcinoma (CSCC): Results from a Post Hoc Exploratory Analysis of a Phase 2 Clinical Trial”. SKIN The Journal of Cutaneous Medicine 5, no. 1 (January 1, 2021): s5. Accessed April 19, 2025. https://skin.dermsquared.com/skin/article/view/1157.